Consensus in silico computational modelling of the p22phox subunit of the NADPH oxidase

https://doi.org/10.1016/j.compbiolchem.2012.05.001Get rights and content

Abstract

The p22phox protein is an essential subunit of the cytochrome b558 of the NADPH oxidase (Nox) complex which by generating reactive oxygen species (ROS) plays important role in regulating cellular function. p22phox stabilises the Nox enzyme, assists in catalytic core maturation and in the meantime provides an anchoring site for cytosolic regulatory subunits to bind. However, the protein structure of the p22phox is still uncertain. In this study we use an in silico computational bioinformatic approach to produce a consensus 3-dimensional model of the p22phox. Based on published protein sequence data of human p22phox and by using transmembrane specific protein prediction algorithms, we found that p22phox consists of two domains: an N-terminal transmembrane domain (124 a.a.) and a C-terminal cytoplasmic domain (71 a.a.). In its predicted most stable form, p22phox contains three transmembrane helices leading to an extracellular N-terminus and an extensive (39 a.a.) extracellular loop between helices 2 and 3. Furthermore, we locate the cytosolic domain phosphorylation site at threonine147 which literature shows is capable of priming the p22phox, in order to accept its binding partners. Our results are consistent with the biological characterisation of p22phox derived from experiments using specific antibody or genetic manipulation. Our 3-D protein model provides insights into the biological function of p22phox and cytochrome b558, and can be used as tool to investigate the regulatory mechanism of Nox isoforms.

Highlights

► A new model for the P22phox protein is presented. ► A comparison of 2, 3 and 4 helix models is discussed. ► Experimental evidence and modelling studies favour the 3 helix model. ► The new model has potential in drug design investigations.

Introduction

The phagocytic type nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 (also called Nox2) is a membrane bound enzyme complex that produces superoxide (O2radical dot) as an essential precursor for other reactive oxygen metabolites critical for oxygen-dependant microbiocidal activity and redox-sensitive cellular processes (Sumimoto, 2008). The physiological importance of Nox2 is demonstrated by the rare genetic disorder chronic granulomatous disease (CGD), where mutations in any regulatory subunit cause defective oxidase activity and the inability of phagocytes to destroy pathogenic microorganisms (Kuhns et al., 2010). The activated human Nox2 isoform is composed of the heterodimeric membrane associated cytochrome b558, consisting of the catalytic subunit gp91phox (a.k.a. Nox2) and p22phox, and regulatory cytosolic subunits (p47phox, p67phox, p40phox and Rac1/2). Nox2 activation and subsequent ROS production is well defined in the literature and occurs when cytosolic components assemble at the membrane anchored by the p22phox subunit (Li and Shah, 2004).

Although Nox-derived reactive oxygen species (ROS) are crucial for normal homeostasis, excessive ROS production due to Nox activation has been found to be associated with oxidative stress-related pathological complications, including coronary heart disease, hypertension, atherosclerosis and type II diabetes, as well as neurological and inflammatory diseases (Lambeth et al., 2008). To date, 7 members of the Nox/DUOX family of ROS producing enzymes have been discovered with an extensive tissue distribution throughout the body, where Nox1–4 are found interacting with p22phox within membranes (Bedard and Krause, 2007).

Despite a wealth of knowledge pertaining to the functional role of the NADPH oxidase, there are currently no complete x-ray crystal structures for any Nox isoform or p22phox. There are reports containing partial x-ray structures of particular domains of the p22phox, e.g. the proline rich region of the p22phox bound to the activated p47phox src homology 3 (SH3) domains (Groemping et al., 2003). Importantly, a protein's structure dictates its overall function and there is only one previous modelling study which looked to identify important aspects of the cytochrome b558, focusing on the catalytic gp91phox subunit and did not include any other oxidase subunits (Taylor et al., 1993). In silico protein modelling is the accumulation of decades of structural biology research and is becoming an important area of interest for functional biologists in studying the p22phox (Taylor et al., 2011). The anchoring subunit has been shown as an important partner for maturation of the catalytic subunit, despite a lack of understanding of the respective mechanistic processes. Moreover, previous analysis of the p22phox protein sequence failed to identify important structural clues in relation to its overall shape, causing conflicting opinions within the literature (Dahan et al., 2002, Groemping and Rittinger, 2005). Furthermore, being a transmembrane (TM) protein, the p22phox contains a large number of hydrophobic residues that compliment the membranes interior. However, lack of an appropriate topology model or x-ray crystal structure limits structural research relating to the manipulation of p22phox as a potential therapeutic target in disease. Importantly, identification of crucial structural aspects allows us to develop new therapies, as well as to better understand disease mechanisms (Li et al., 2008).

The role of p22phox in the production of an active Nox complex is important in the regulation of normal homeostasis. Currently there is a lack of consensus between the accepted topology for the p22phox and therefore its role in overall Nox stability. In this study we present a novel model of the p22phox subunit based on a comparison of computational homology modelling methods resulting in a consensus model which satisfies the current understanding of p22phox biology.

Section snippets

p22phox Model

The x-ray crystal structure for p22phox is incomplete within the Protein Databank at the European Bioinformatics Institute with only an 18 amino acid section encoding the proline rich region (PRR), covering residues 149–167 of the full sequence existing as part of another structure at a resolution of 1.8 Ǻ (PDB ID: 1OV3).

Sequence data

The full Homo sapiens protein sequence data for p22phox was obtained from the UniProtKB database. The accession number was P13498, with the entry name CY24A_HUMAN. The

Sequence analysis leads towards a 3 transmembrane model

The full human sequence for the p22phox was submitted to mathematical algorithms which calculate the hydrophobicity of clusters of residues for topology analysis as summarised in Table 1. Importantly, 85% of all transmembrane specific algorithms returned a three-transmembrane model for the p22phox. Moreover, four transmembrane helix containing models returned topology results with helices <10 residues, meaning this region would not span the entire membrane. Furthermore, a small peak in

Discussion

The p22phox is an integral component of the cytochrome b558, acting as an important regulator of Nox stability and subsequent ROS production. Despite its fundamental role, it is the least understood subunit of the NADPH oxidase family and many groups are trying to utilise a multi-disciplinary approach to elucidate key structural features. Initial work was directed towards a genetic manipulation approach to identify important interlinked structure-function aspects which stem from clinically

Acknowledgements

We acknowledge the provision of a studentship from the BBSRC and Welcome trust for one of us (DM) and the support of the Surrey Pathfinder fund.

References (28)

  • V. Cojocaru et al.

    Structure and dynamics of the membrane-bound cytochrome P450 2C9

    PLoS Computational Biology

    (2011)
  • Y. Groemping et al.

    Activation and assembly of the NADPH oxidase: a structural perspective

    Biochemical Journal

    (2005)
  • D.B. Kuhns et al.

    Residual NADPH oxidase and survival in chronic granulomatous disease

    New England Journal of Medicine

    (2010)
  • J.D. Lambeth et al.

    NOX enzymes as novel targets for drug development

    Seminars in Immunopathology

    (2008)
  • Cited by (0)

    View full text